WALD Earnings Prediction
The chart below shows how WALD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, WALD sees a +1.09% change in stock price 10 days leading up to the earnings, and a +10.87% change 10 days following the report. On the earnings day itself, the stock moves by +1.11%. This data can give you a slight idea of what to expect for the next quarter's release.
WALD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
--
--
--
Gross Margin
--
--
--
Operating Margin
--
--
--
Net Margin
--
--
--
EPS
--
--
--
No Data Available
WALD Earnings Analysis
Waldencast PLC Corporation (WALD.O) Earnings Conference Call
Positive
Prestige Beauty Growth: Prestige Beauty grew 7% in 2024, with Prestige Makeup growing 5% and Professional Skincare growing 8%.
Q4 Growth Surge: Milk Makeup grew 31.9% in Q4 2024, reflecting channel expansion and initial shipments to Ulta Beauty.
Q4 Revenue Growth: Obagi Medical delivered 27.7% comparable net revenue growth in Q4 2024, driven by accelerated performance in the U.S. physician dispense and e-commerce channel.
EBITDA Growth and Margin Expansion: Adjusted EBITDA doubled to $11.2 million in Q4 2024, with adjusted EBITDA margin expansion of 530 basis points year-over-year to reach 15.5%.
Net Revenue Increase: Net revenue for fiscal year 2024 reached $273.9 million, a robust 27.5% increase in comparable growth.
Adjusted Gross Profit Increase: Adjusted gross profit rose 35.3% to $203.6 million in fiscal year 2024, with an adjusted gross profit margin of 74.3%.
EBITDA Growth and Margin Expansion: Adjusted EBITDA for fiscal year 2024 grew 65.1% to $40.3 million, with adjusted EBITDA margin expanding to 14.7%.
EBITDA Cash Conversion Ratio: The company achieved a robust adjusted EBITDA to cash conversion ratio of 78.8% in 2024, due to effective working capital management.
Gross Margin Advantage: Waldencast's adjusted gross margin stands 430 basis points above the industry average, allowing for reinvestment in high ROI business drivers.
Instagram Growth Rate: Milk Makeup is a leading clean makeup brand with 2.8 million Instagram followers, growing five times faster than the market in the U.S.
Leading Medical Skincare Brand: Obagi Medical is the number one U.S. physician recommended medical grade skincare brand, consistently delivering breakthrough technology for transformative results.
Flywheel Effect Success: Waldencast's Flywheel Effect has already shown dividends, with the company growing three and a half times faster than the average of its peer group in fiscal year 2024.
Negative
Consumption Growth Challenges: Despite a strong overall performance, the company faced challenges with lower-than-expected consumption growth due to retailer inventory adjustments, which impacted Milk Makeup's anticipated growth.
Profit Margin Decline: The adjusted gross profit margin for Obagi Medical contracted by 130 basis points to 78.7%, indicating a reduction in profitability despite strong sales growth.
Cash Flow Impact: A significant portion of cash is currently being used to cover non-recurring expenses related to an ongoing regulatory investigation, which may hinder cash generation in the short term.
Flat Net Revenue Growth: The company anticipates relatively flat net revenue growth in the first quarter of 2025 due to inventory adjustments and the timing of product launches, which may affect overall performance in the near term.
